CANADA LIFE ASSURANCE Co Has $1.31 Million Position in U.S. Physical Therapy, Inc. (NYSE:USPH)

CANADA LIFE ASSURANCE Co decreased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,704 shares of the company’s stock after selling 247 shares during the period. CANADA LIFE ASSURANCE Co owned approximately 0.10% of U.S. Physical Therapy worth $1,305,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of USPH. CBIZ Investment Advisory Services LLC raised its holdings in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock valued at $29,000 after purchasing an additional 122 shares during the last quarter. Venturi Wealth Management LLC raised its holdings in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company’s stock valued at $64,000 after purchasing an additional 704 shares during the last quarter. Pacer Advisors Inc. purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at about $113,000. Mutual of America Capital Management LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at about $203,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at about $257,000.

U.S. Physical Therapy Trading Up 0.8 %

Shares of USPH opened at $71.07 on Tuesday. The firm’s 50 day simple moving average is $74.30 and its 200 day simple moving average is $84.40. The company has a market capitalization of $1.08 billion, a P/E ratio of 75.61, a P/E/G ratio of 3.54 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $108.14.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were given a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.53%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio is presently 97.83%.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on USPH. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. JPMorgan Chase & Co. reduced their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday, March 19th. JMP Securities reiterated a “market outperform” rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, April 22nd. William Blair reiterated a “market perform” rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. Finally, StockNews.com lowered shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Thursday, April 17th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, U.S. Physical Therapy has a consensus rating of “Moderate Buy” and a consensus price target of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. This represents a 19.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.